Dr. Rowan Chlebowski, medical oncologist at the Los Angeles
Biomedical Research Institute at Harbor-UCLA Medical Center, led a study
published in Journal of the National Cancer Institute. The study
included 42,000 patients over 11 years. In that time frame, 25,000
women had hormone therapy which included progestin and estrogen. After
the 11 year time period 2,200 women had been diagnosed with breast
cancer.
"Women starting within months of menopause had about a threefold greater risk than women starting 10 years after menopause," Chlebowski said.
About two thirds of the women at the beginning of the study were already in their 60s, well into menopause. About a third of them were just starting or coming close to menopause around age 50.
The main point of the study's results show that timing of the hormone therapy compared with menopause matters.
For the full article, visit http://healthyliving.msn.com/diseases/breast-cancer/more-evidence-shows-hormone-therapy-may-increase-breast-cancer-risk.
"Women starting within months of menopause had about a threefold greater risk than women starting 10 years after menopause," Chlebowski said.
About two thirds of the women at the beginning of the study were already in their 60s, well into menopause. About a third of them were just starting or coming close to menopause around age 50.
The main point of the study's results show that timing of the hormone therapy compared with menopause matters.
For the full article, visit http://healthyliving.msn.com/diseases/breast-cancer/more-evidence-shows-hormone-therapy-may-increase-breast-cancer-risk.
No comments:
Post a Comment